COVID-19 vaccine maker CureVac pops 200% in debut Leave a Comment / Business Investments, Business News / By ekiensnews Yahoo Finance’s Anjalee Khemlani and Zack Guzman discuss COVID-19 vaccine maker Curevac’s public debut and the UK Government signing vaccine deals with J&J and Novavax.
Yahoo Finance’s Anjalee Khemlani and Zack Guzman discuss COVID-19 vaccine maker Curevac’s public debut and the UK Government signing vaccine deals with J&J and Novavax.